search
Back to results

The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial

Primary Purpose

Male Infertility, Infertility, Traditional Chinese Medication (TCM)

Status
Recruiting
Phase
Phase 2
Locations
Singapore
Study Type
Interventional
Intervention
Bu Shen Yi Jing Pill
Placebo Drug
Sponsored by
KK Women's and Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Male Infertility focused on measuring Infertility, Sperm, Traditional Medicine

Eligibility Criteria

21 Years - 49 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Duration of subfertility (both primary and secondary) ≥ 1 year;
  • Any or combination of the three abnormal semen parameters, defined according to the 2010 WHO criteria, including

    • Oligozoospermia, with sperm concentration less than 15 x 10^6,
    • Teratozoospermia, with normal sperm morphology less than 4%, and
    • Asthenozoospermia, with total sperm motility less than 40%, or progressive sperm motility less than 32%.
  • Diagnosed with TCM syndrome of Kidney Deficiency Based on a prominent TCM diagnosis textbook known as TCM Diagnostics, the main symptoms patients need to fulfil for Kidney Deficiency are either nocturnal polyuria or lower back pain. In addition, patients need to fulfil any 1 of the secondary symptoms, including fatigue; dizziness; tinnitus or deafness; memory loss; excessive urination; low libido; wet dreams; premature ejaculation; presence of feverish palms and soles or night sweats; dry mouth or throat; cold intolerance or preference for warmth; poor sleep quality. Presence of both 1 main symptom and 1 secondary symptom allows for the diagnosis of the Kidney Deficiency syndrome.

Patients who meet all three criteria mentioned above will be included in the study.

Exclusion Criteria:

  • Azoospermia and severe oligoasthenoteratozoospermia;
  • Aspermia;
  • Varicocele;
  • Recent urogenital infections;
  • Y chromosome deletions;
  • Abnormal karyotypes
  • History of chemotherapy and / or radiotherapy;
  • Patients on fertility supplements or supplements marketed to improve fertility;
  • Patients with uncontrolled diabetes or/and hypertension; with uncontrolled chronic medical conditions
  • Patients currently already on BSYJ pills treatment

Sites / Locations

  • KK Women's and Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Placebo

Bu Shen Yi Jing Pill

Arm Description

Patients in this arm will be given a placebo pill that resembles the actual Bu Shen Yi Jing Pill.

Patients in this arm will be given the BSYJ Pill.

Outcomes

Primary Outcome Measures

To determine the change in sperm volume from baseline after treatment with BSYJ pill
From sperm samples analyses
To determine the change in sperm morphology from baseline after treatment with BSYJ pill
From sperm samples analyses
To determine the change in sperm motility from the baseline after treatment with BSYJ pill
From sperm samples analyses
To determine the change in sperm concentration from the baseline after treatment with BSYJ pill
From sperm samples analyses

Secondary Outcome Measures

To determine the clinical pregnancy rate and successful delivery rate after BSYJ pill
Defined by the number of pregnancies and subsequent actual births after commencement of BSYJ pill
To study the safety and determine the changes in blood profile after treatment with BSYJ pill
Defined by changes in participant's full blood count, renal panel, liver function test and hormone profile.

Full Information

First Posted
December 29, 2021
Last Updated
October 2, 2022
Sponsor
KK Women's and Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05290558
Brief Title
The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial
Official Title
The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 7, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
KK Women's and Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study aims to evaluate the safety and efficacy of Bu Shen Yi Jing (BSYJ) Pill , a type of traditional Chinese medicine, in improving male subfertility and semen parameters.
Detailed Description
Subfertility is defined as a failure to conceive after 1 year of regular unprotected intercourse. Impaired fertility affects 10 to 15% of couples and male factor is the cause of subfertility in 25 to 40% of couples. With increasing paternal age, semen volume, sperm motility and the percentage of sperm with normal morphology decreases. The majority of men who present with subfertility have either abnormal sperm density, motility or morphology, or a combination of the above, and treatment for this condition is varied and empirical. There is a paucity of studies and randomized controlled trials to guide treatment of male factor subfertility. Various antioxidant formulations and multivitamins have been used empirically but have not been shown consistently to improve sperm counts and viability. When treatment fails, assisted reproduction will be the last resort. All assisted reproduction treatments are associated with medical, financial and emotional burden. Given the lack of proven treatment options in Western Medicine, Traditional Chinese Medicine (TCM) may provide a viable complementary treatment option. One such option is the Bu Shen Yi Jing (BSYJ) pill. A clinical observational study conducted by the team in Singapore Thong Chai Medical on subfertile male patients with poor sperm quality and a body constitution of Kidney Deficiency showed that 2 courses of BSYJ pill over a 6 months' duration resulted in successful conception of 33% of azoospermic male patients (n = 60). In a subgroup of patients where serial sperm analysis was available (n=10), the percentage of sperm with grade A motility increased from a median of 22.6 ± 2.4% pre-treatment to 35.1 ± 3.2% post treatment (p < 0.05); and the hyaluronic binding assay improved from 33.2 ± 2.4% to 72 ± 4.6% (p < 0.05). This suggests that BSYJ pills possibly works on improving the motility of the sperms in patients having the Kidney deficiency body constitution. As such, this study aims to validate these hypotheses and anecdotal evidence by conducting a safety and efficacy study of the BSYJ pill on a prospective cohort.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Male Infertility, Infertility, Traditional Chinese Medication (TCM), Reproductive Issues
Keywords
Infertility, Sperm, Traditional Medicine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
This is a double-blinded randomised control trial. Participants will be randomised using block randomization by a pre-determined randomisation schedule generated by a biostatistician in block size of 4. Enrolment and assignment of intervention will be carried out by an investigator. The investigators will perform block randomization of the subjects in blocks of 4 in the ratio of 1:1 such that 2 will be assigned to treatment and 2 will be assigned to placebo.
Masking
ParticipantCare Provider
Masking Description
This is a double-blind study. The randomization master list will be kept with the investigator and both patients and physician will be blinded to the treatment received.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Patients in this arm will be given a placebo pill that resembles the actual Bu Shen Yi Jing Pill.
Arm Title
Bu Shen Yi Jing Pill
Arm Type
Active Comparator
Arm Description
Patients in this arm will be given the BSYJ Pill.
Intervention Type
Drug
Intervention Name(s)
Bu Shen Yi Jing Pill
Other Intervention Name(s)
BSYJ Pill
Intervention Description
Bu Shen Yi Jing Pill contained Radix Pseudostellaria, Fructus Lycii, Radix Et Rhizoma Salviae, Rhizoma Dioscorea, Semen Plantaginis, Semen Cuscuta, Patriniae Herba, Herba Epimedii, Radix Ophiopogonis, Fructus Rubi, Fructus Corni, Bupleurum roots, Fructus Schisandrae Chinensis, Radix Et Rhizoma Glycyrrhizae. Dosage of the study drug is as follows: 3 pills each time, for 3 times a day, taken for 6 days every week for 1 year
Intervention Type
Drug
Intervention Name(s)
Placebo Drug
Other Intervention Name(s)
Control drug
Intervention Description
Placebo contains the ingredients: grounded black rice and permitted colouring. The ingredients are encapsulated within a gelatine capsule. Dosage of the study drug is as follows: 3 pills each time, for 3 times a day, taken for 6 days every week for 1 year
Primary Outcome Measure Information:
Title
To determine the change in sperm volume from baseline after treatment with BSYJ pill
Description
From sperm samples analyses
Time Frame
1 year
Title
To determine the change in sperm morphology from baseline after treatment with BSYJ pill
Description
From sperm samples analyses
Time Frame
1 year
Title
To determine the change in sperm motility from the baseline after treatment with BSYJ pill
Description
From sperm samples analyses
Time Frame
1 year
Title
To determine the change in sperm concentration from the baseline after treatment with BSYJ pill
Description
From sperm samples analyses
Time Frame
1 year
Secondary Outcome Measure Information:
Title
To determine the clinical pregnancy rate and successful delivery rate after BSYJ pill
Description
Defined by the number of pregnancies and subsequent actual births after commencement of BSYJ pill
Time Frame
2 year
Title
To study the safety and determine the changes in blood profile after treatment with BSYJ pill
Description
Defined by changes in participant's full blood count, renal panel, liver function test and hormone profile.
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
To assess the common side effects of the BSYJ pill
Description
Participant reported symptoms of excessive heat syndrome such as ulcers and mouth dryness.
Time Frame
1 year
Title
To assess the common gastrointestinal side effects of the BSYJ pill
Description
Participant reported symptoms of gastrointestinal symptoms such as indigestion and appetite reduction.
Time Frame
1 year
Title
To evaluate safety profile of BSYJ pill
Description
Participants will be assessed frequently to pick up any side effects noted after commencement of BSYJ pill
Time Frame
Up to 1 year after recruitment
Title
Change from baseline severity based on TCM symptom scoring questionnaire
Description
As BSYJ pills target the TCM syndrome of Kidney Qi deficiency, symptoms related to Kidney Qi deficiency syndrome, which includes frequent urination and back pain, fatigue and dizziness, may be improved through this research.
Time Frame
1 year
Title
Number of participants with improvement in TCM syndrome of Kidney Qi deficiency from baseline according to the TCM symptom scoring questionnaire Stagnation
Description
As BSYJ pills target the TCM syndrome of Kidney Qi deficiency, symptoms related to Kidney Qi deficiency syndrome, which includes frequent urination and back pain, fatigue and dizziness, may be improved through this research.
Time Frame
1 year
Title
Patient's basic demographics
Description
Defined by age, ethnicity, marital status
Time Frame
1 year
Title
Patient's partner's basic demographics
Description
Defined by age, ethnicity, marital status
Time Frame
1 year
Title
Patients's anthropometry
Description
Defined by height, weight and body mass index based on weight (kg) /height (m)2
Time Frame
1 year
Title
Number of participants who smoke
Description
Self-reported
Time Frame
1 year
Title
Number of participants who take alcohol regularly
Description
Self-reported based on the amount and frequency of alcohol intake
Time Frame
1 year
Title
Number of participants who have dietary restrictions
Description
Self-reported
Time Frame
1 year
Title
Number of participants with occupational exposures to chemicals
Description
Self-reported
Time Frame
1 year
Title
Number of participants with exposure to hot baths or jacuzzi
Description
Self-reported
Time Frame
1 year
Title
Number of participants who uses recreational drugs
Description
Self-reported
Time Frame
1 year
Title
Number of participants who exercise regularly
Description
Self-reported
Time Frame
1 year
Title
Number of patients with significant medical history
Description
Self-reported details of medical history
Time Frame
1 year
Title
Number of patients with significant surgical history
Description
Self-reported details of surgical history
Time Frame
1 year
Title
Number of patients on regular medications
Description
Self-reported details of types of regular medications
Time Frame
1 year
Title
Number of patients with drug allergies
Description
Self-reported details of drug allergies
Time Frame
1 year
Title
Number of patients who take supplements
Description
Self-reported details of the type of supplements taken
Time Frame
1 year
Title
Number of patients who take steroids
Description
Self-reported
Time Frame
1 year
Title
Number of patients with previous history of sexually transmitted disease
Description
Self-reported details of sexually transmitted disease
Time Frame
1 year
Title
Number of patients with previous history of genital trauma
Description
Self-reported details of genital trauma
Time Frame
Since birth
Title
Patient's fertility history
Description
Determined by the number of years of attempts at conception, sexual intercourse frequency, number of paternity (including current and/or previous partners), previous fertility treatments and medications
Time Frame
1 year
Title
Patient's partner's fertility history
Description
Determined by the number of years of attempts at conception, sexual intercourse frequency, number of maternity (including current and/or previous partners), previous fertility treatments and medications, and menstrual history
Time Frame
1 year

10. Eligibility

Sex
Male
Gender Based
Yes
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
49 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Duration of subfertility (both primary and secondary) ≥ 1 year; Any or combination of the three abnormal semen parameters, defined according to the 2010 WHO criteria, including Oligozoospermia, with sperm concentration less than 15 x 10^6, Teratozoospermia, with normal sperm morphology less than 4%, and Asthenozoospermia, with total sperm motility less than 40%, or progressive sperm motility less than 32%. Diagnosed with TCM syndrome of Kidney Deficiency Based on a prominent TCM diagnosis textbook known as TCM Diagnostics, the main symptoms patients need to fulfil for Kidney Deficiency are either nocturnal polyuria or lower back pain. In addition, patients need to fulfil any 1 of the secondary symptoms, including fatigue; dizziness; tinnitus or deafness; memory loss; excessive urination; low libido; wet dreams; premature ejaculation; presence of feverish palms and soles or night sweats; dry mouth or throat; cold intolerance or preference for warmth; poor sleep quality. Presence of both 1 main symptom and 1 secondary symptom allows for the diagnosis of the Kidney Deficiency syndrome. Patients who meet all three criteria mentioned above will be included in the study. Exclusion Criteria: Azoospermia and severe oligoasthenoteratozoospermia; Aspermia; Varicocele; Recent urogenital infections; Y chromosome deletions; Abnormal karyotypes History of chemotherapy and / or radiotherapy; Patients on fertility supplements or supplements marketed to improve fertility; Patients with uncontrolled diabetes or/and hypertension; with uncontrolled chronic medical conditions Patients currently already on BSYJ pills treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tat Xin Ee, MD
Phone
97717807
Email
ee.tat.xin@singhealth.com.sg
First Name & Middle Initial & Last Name or Official Title & Degree
Chee Wai Ku, MD
Phone
98365742
Email
gmskcw@nus.edu.sg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tat Xin Ee, MD
Organizational Affiliation
KK Women's and Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
KK Women's and Children's Hospital
City
Singapore
ZIP/Postal Code
229899
Country
Singapore
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tat Xin Ee, MD
Phone
97717807
Email
ee.tat.xin@singhealth.com.sg

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Therapeutic Effects of Bu Shen Yi Jing Pill on Semen Quality in Sub Fertile Males: a Randomized Controlled Trial

We'll reach out to this number within 24 hrs